Content by The Scientist Creative Services Team

In this webinar, Tim Heiseler will discuss the importance of assay design when measuring binding kinetics and affinity values, as well as strategies to mitigate avidity effects.

Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.

The latest synthetic and chemical reagents offer researchers more flexibility, stability, and consistency when working with their cells.

A novel instrument combines fluorescence-activated cell sorting, imaging flow cytometry, and spectral flow cytometry to advance cell population examination.

Next-generation sequencing (NGS) core facility scientists and researchers new to NGS discuss their fruitful collaborations, highlighting how to receive expert help from genomics facilities.

In this webinar, Dr. Kevin Wang will discuss a precision medicine approach for treating traumatic brain injury which uses phenotype biomarkers to monitor disease course and develop novel therapies.

Learn how the latest AI-driven technology uses morphology to comprehensively analyze and sort cell populations.

In this webinar, Bryan McQueen will discuss how a novel in vitro model of inflammatory bowel disease paves the way toward scientific discovery and developing cost-effective therapies.

A more focused investigation for more in-depth answers.

New developments in non-specific fluorescence quenching offer researchers clearer pictures and more multiplexing possibilities.

In this webinar, Noah Allen will explore how spaceflight changes the way organs and systems function, focusing on immune-mediated liver damage.

Scientists present the latest research on infection prevention and treatment, including COVID-19 and tropical infectious diseases.

Fecal transplants may help scientists improve current treatment strategies for anorexia nervosa.

Researchers harness the power of familiar methods to advance science. 

Xitiz Chamling shares how advances in human stem cell and gene editing technologies fuel his drive for better multiple sclerosis drug screening platforms.